Cite

HARVARD Citation

    Huber, V. et al. (2021). Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients. Journal for immunotherapy of cancer. 9 (2), p. . [Online]. 
  
Back to record